Oncogene-induced replication stress has been recognized as a major cause of genome instability in cancer cells. Increased expression of cyclin E1 caused by amplification of the CCNE1 gene is a common cause of replication stress in various cancers. Protein phosphatase magnesium-dependent 1 delta (PPM1D) is a negative regulator of p53 and has been implicated in termination of the cell cycle checkpoint. Amplification of the PPM1D gene or frameshift mutations in its final exon promote tumorigenesis. Here, we show that PPM1D activity further increases the replication stress caused by overexpression of cyclin E1. In particular, we demonstrate that cells expressing a truncated mutant of PPM1D progress faster from G1 to S phase and fail to complete licensing of the replication origins. In addition, we show that transcription-replication collisions and replication fork slowing caused by CCNE1 overexpression are exaggerated in cells expressing the truncated PPM1D. Finally, replication speed and accumulation of focal DNA copy number alterations caused by induction of CCNE1 expression was rescued by pharmacological inhibition of PPM1D. We propose that increased activity of PPM1D suppresses the checkpoint function of p53 and thus promotes genome instability in cells expressing the CCNE1 oncogene.

Department of Medical Oncology University Medical Center Groningen University of Groningen The Netherlands

Department of Pathology and Medical Biology University Medical Center Groningen University of Groningen The Netherlands

Institute of Molecular Cancer Research University of Zurich Switzerland

Laboratory of Cancer Cell Biology Institute of Molecular Genetics Czech Academy of Sciences Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc24007850

003      

CZ-PrNML

005      

20240423160330.0

007      

ta

008      

240412s2024 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1002/1878-0261.13433 $2 doi

035    __

$a (PubMed)37067201

040    __

$a ABA008 $b cze $d ABA008 $e AACR2

041    0_

$a eng

044    __

$a xxu

100    1_

$a Martinikova, Andra S $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic

245    10

$a PPM1D activity promotes the replication stress caused by cyclin E1 overexpression / $c AS. Martinikova, M. Stoyanov, A. Oravetzova, YP. Kok, S. Yu, J. Dobrovolna, P. Janscak, M. van Vugt, L. Macurek

520    9_

$a Oncogene-induced replication stress has been recognized as a major cause of genome instability in cancer cells. Increased expression of cyclin E1 caused by amplification of the CCNE1 gene is a common cause of replication stress in various cancers. Protein phosphatase magnesium-dependent 1 delta (PPM1D) is a negative regulator of p53 and has been implicated in termination of the cell cycle checkpoint. Amplification of the PPM1D gene or frameshift mutations in its final exon promote tumorigenesis. Here, we show that PPM1D activity further increases the replication stress caused by overexpression of cyclin E1. In particular, we demonstrate that cells expressing a truncated mutant of PPM1D progress faster from G1 to S phase and fail to complete licensing of the replication origins. In addition, we show that transcription-replication collisions and replication fork slowing caused by CCNE1 overexpression are exaggerated in cells expressing the truncated PPM1D. Finally, replication speed and accumulation of focal DNA copy number alterations caused by induction of CCNE1 expression was rescued by pharmacological inhibition of PPM1D. We propose that increased activity of PPM1D suppresses the checkpoint function of p53 and thus promotes genome instability in cells expressing the CCNE1 oncogene.

650    _2

$a lidé $7 D006801

650    12

$a nádorový supresorový protein p53 $x genetika $x metabolismus $7 D016159

650    12

$a nádory $7 D009369

650    _2

$a cyklin E $x genetika $x metabolismus $7 D019927

650    _2

$a nestabilita genomu $7 D042822

650    _2

$a proteinfosfatasa 2C $x genetika $x metabolismus $7 D000071636

655    _2

$a časopisecké články $7 D016428

700    1_

$a Stoyanov, Miroslav $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic

700    1_

$a Oravetzova, Anna $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic

700    1_

$a Kok, Yannick P $u Department of Medical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands

700    1_

$a Yu, Shibo $u Department of Pathology and Medical Biology, University Medical Center Groningen, University of Groningen, The Netherlands

700    1_

$a Dobrovolna, Jana $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic

700    1_

$a Janscak, Pavel $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic $u Institute of Molecular Cancer Research, University of Zurich, Switzerland

700    1_

$a van Vugt, Marcel $u Department of Medical Oncology, University Medical Center Groningen, University of Groningen, The Netherlands $1 https://orcid.org/0000000232024678

700    1_

$a Macurek, Libor $u Laboratory of Cancer Cell Biology, Institute of Molecular Genetics, Czech Academy of Sciences, Prague, Czech Republic $1 https://orcid.org/0000000209871238 $7 xx0128728

773    0_

$w MED00167281 $t Molecular oncology $x 1878-0261 $g Roč. 18, č. 1 (2024), s. 6-20

856    41

$u https://pubmed.ncbi.nlm.nih.gov/37067201 $y Pubmed

910    __

$a ABA008 $b sig $c sign $y - $z 0

990    __

$a 20240412 $b ABA008

991    __

$a 20240423160326 $b ABA008

999    __

$a ok $b bmc $g 2081701 $s 1217617

BAS    __

$a 3

BAS    __

$a PreBMC-MEDLINE

BMC    __

$a 2024 $b 18 $c 1 $d 6-20 $e 20231016 $i 1878-0261 $m Molecular oncology $n Mol Oncol $x MED00167281

GRA    __

$a 20-11931S $p Grantová Agentura České Republiky

GRA    __

$a LM2018129 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a LTAUSA19096 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a LX22NPO5102 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a CZ.02.1.01/0.0/0.0/18_046/0016045 $p Ministerstvo Školství, Mládeže a Tělovýchovy

GRA    __

$a KFS-5484-02-2022 $p Swiss Cancer League

GRA    __

$a 21-22593X $p Czech Science Foundation

GRA    __

$a 68378050-KAV-NPUI $p RVO

LZP    __

$a Pubmed-20240412